TAKARA BIO USA, INC.

TAKARA BIO USA, INC. specializes in the manufacturing and supply of high-purity biological reagents and laboratory instrumentation critical to advanced genomic research and clinical applications. Their core capabilities include GMP-grade production of viral transduction enhancers such as Retronectin, reverse transcriptase kits like SmartScribe, and next-generation sequencing reagents including Smart-Seq mRNA libraries with unique dual indexing and UMIs. The company delivers precision-engineered molecular biology tools for single-cell RNA sequencing, gene expression analysis, and nucleic acid amplification workflows, serving laboratories requiring stringent quality control and reproducibility. Their technical expertise centers on scalable, cGMP-compliant manufacturing of non-diagnostic biological products, with demonstrated proficiency in integrating proprietary chemistries into end-to-end research workflows for sensitive genomic applications. The contractor maintains a strong, consistent relationship with the Department of Health and Human Services, providing mission-critical reagents and instrumentation for research initiatives across NIH, CDC, and other HHS components. Work includes direct supply of research-grade molecular tools used in infectious disease, immunology, and precision medicine studies. A single contract with the Environmental Protection Agency reflects past support for specialized instrument maintenance, though HHS remains the dominant and consistent partner. TAKARA BIO USA’s primary industry focus is biological product manufacturing (NAICS 325414), with additional activity in analytical laboratory instrument manufacturing (334516) and surgical appliance supply (339113). The company positions itself as a niche supplier of high-complexity, research-grade biological reagents for government-funded life sciences programs, emphasizing reproducibility, regulatory compliance, and integration with next-generation sequencing platforms. As a 2L entity based in San Jose, California, TAKARA BIO USA operates as a specialized manufacturer without federal certifications. Its geographic presence supports federal research infrastructure on the West Coast, serving as a reliable source for mission-critical biological materials within the U.S. government’s biomedical research ecosystem.